FCCM
SGMO

First City Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

First City Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100
Closed -$605 – 453
2016
Q1 		$605 Sell
100
-900
-90% -$5.4K ﹤0.01% 636
2015
Q4 		$9.13K Buy
1,000
+100
+11% +$771 0.01% 478
2015
Q3 		$5.08K Hold
900
– – ﹤0.01% 506
2015
Q2 		$9.98K Hold
900
– – 0.01% 432
2015
Q1 		$14.1K Hold
900
– – 0.01% 402
2014
Q4 		$13.7K Hold
900
– – 0.01% 423
2014
Q3 		$9.71K Hold
900
– – 0.01% 445
2014
Q2 		$13.7K Hold
900
– – 0.01% 431
2014
Q1 		$16.3K Buy
+900
New +$17.3K 0.01% 396

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

First City Capital Management's SGMO Position: Q2 2016 in Review

First City Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2016, closing a stake of 100 shares — an estimated $605 sold.

First City Capital Management first reported a position in SGMO in Q1 2014 and held it in 9 quarters. The position peaked at $16.3K in Q1 2014. 136 funds tracked by Wall St. Rank hold SGMO as of Q2 2016.

  • First City Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
  • First City Capital Management sold 100 SANGAMO THERAPEUTICS INC shares in Q2 2016, an estimated $605.
  • First City Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 9 quarters.
  • First City Capital Management's SANGAMO THERAPEUTICS INC position peaked at $16.3K in Q1 2014.
  • 136 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2016.

Based on First City Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.